1. Home
  2. VRAX vs DSS Comparison

VRAX vs DSS Comparison

Compare VRAX & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • DSS
  • Stock Information
  • Founded
  • VRAX 2013
  • DSS 1984
  • Country
  • VRAX United Kingdom
  • DSS United States
  • Employees
  • VRAX N/A
  • DSS N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • DSS Containers/Packaging
  • Sector
  • VRAX Health Care
  • DSS Consumer Discretionary
  • Exchange
  • VRAX Nasdaq
  • DSS Nasdaq
  • Market Cap
  • VRAX 5.9M
  • DSS 8.0M
  • IPO Year
  • VRAX 2022
  • DSS N/A
  • Fundamental
  • Price
  • VRAX $1.05
  • DSS $0.95
  • Analyst Decision
  • VRAX Strong Buy
  • DSS
  • Analyst Count
  • VRAX 1
  • DSS 0
  • Target Price
  • VRAX $3.00
  • DSS N/A
  • AVG Volume (30 Days)
  • VRAX 302.3K
  • DSS 13.4K
  • Earning Date
  • VRAX 02-05-2025
  • DSS 05-13-2025
  • Dividend Yield
  • VRAX N/A
  • DSS N/A
  • EPS Growth
  • VRAX N/A
  • DSS N/A
  • EPS
  • VRAX N/A
  • DSS N/A
  • Revenue
  • VRAX $84,872.00
  • DSS $19,097,000.00
  • Revenue This Year
  • VRAX $5,169.18
  • DSS N/A
  • Revenue Next Year
  • VRAX $66.97
  • DSS N/A
  • P/E Ratio
  • VRAX N/A
  • DSS N/A
  • Revenue Growth
  • VRAX 7.03
  • DSS N/A
  • 52 Week Low
  • VRAX $0.60
  • DSS $0.77
  • 52 Week High
  • VRAX $9.00
  • DSS $1.94
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 46.14
  • DSS 53.59
  • Support Level
  • VRAX $0.91
  • DSS $0.86
  • Resistance Level
  • VRAX $1.09
  • DSS $1.00
  • Average True Range (ATR)
  • VRAX 0.11
  • DSS 0.06
  • MACD
  • VRAX 0.03
  • DSS 0.00
  • Stochastic Oscillator
  • VRAX 44.23
  • DSS 70.83

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

Share on Social Networks: